LLY logo

Eli Lilly and Company

LLY
Healthcare|Drug Manufacturers - General|US
$1354.00
-10.73 (-0.79%)
DCF Value
$771.70
Tangible Book / Share
$13.81
Graham Number
$177.24
Cash / Share
$5.48

Clinical Trials (500)

TrialConditionsPhaseStatusEnrollmentDesignDrug
NCT04372277
Taltz in Combination With Enstilar for Psoriasis
Psoriasis
P4
Recruiting25Open-labelEnstilar
NCT07613294
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
P3
Recruiting252RCT, Double-blindLepodisiran, Placebo
NCT06972472
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Obesity, Overweight
P3
Active600RCT, Double-blindOrforglipron, Placebo
NCT06383390
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)
P3
Active10,000RCT, Double-blindRetatrutide, Placebo
NCT05559359
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis, Eczema
P3
Active377RCT, Double-blindLebrikizumab, Placebo, Topical Corticosteroid (TCS)
NCT07279688
Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica
Polymyalgia Rheumatica (PMR)
P3
Recruiting140RCT, Double-blindBaricitinib 4 MG Oral Tablet, Baricitinib 2 MG Oral Tablet, Placebo 4 mg, Placebo 2 mg
NCT06260722
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Diabetes Mellitus, Type 2
P3
Active1,250RCT, Open-labelRetatrutide, Semaglutide
NCT05509777
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Crohn's Disease
P3
Recruiting90Open-labelMirikizumab
NCT05508789
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
Alzheimer Disease, Dementia
P3
Active1,500RCT, Double-blindDonanemab, Placebo
NCT07157774
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
P3
Recruiting10,450RCT, Double-blindMuvalaplin, Placebo
NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Obesity, Overweight
P3
Recruiting1,980RCT, Double-blindEloralintide, Placebo
NCT07222332
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
P3
Recruiting300RCT, Double-blindBaricitinib, Placebo
NCT06672939
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Obesity, Overweight
P3
Recruiting150RCT, Double-blindOrforglipron, Placebo
NCT02763566
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
Breast Cancer
P3
Active463RCT, Double-blindAbemaciclib, Anastrozole, Letrozole, Placebo, Fulvestrant
NCT07219953
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
P3
Recruiting1,100RCT, Double-blindLY3537031, Placebo
NCT06075667
A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
P3
Active160RCT, Double-blindTirzepatide, Placebo
NCT05026866
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
Alzheimer Disease
P3
Active2,996RCT, Double-blindDonanemab, Placebo
NCT07817875
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Obesity
P3
Recruiting150RCT, Double-blindTirzepatide, Placebo
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Crohn's Disease, Obesity or Overweight
P3
Recruiting290RCT, Double-blindMirikizumab, Mirikizumab, Tirzepatide, Placebo
NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative Colitis, Obesity or Overweight
P3
Recruiting350RCT, Double-blindMirikizumab, Mirikizumab, Tirzepatide, Placebo
NCT07571161
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
Alzheimer Disease
P3
Recruiting140RCT, Double-blindDonanemab, Placebo
NCT06859268
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
Obesity
P3
Active643RCT, Double-blindRetatrutide, Placebo
NCT04956640
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms
P1P2
Active540Open-labelLY3537982, Pembrolizumab, Cetuximab, Pemetrexed, Cisplatin, Carboplatin
NCT07269210
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Severe Hypertriglyceridemia
P2
Recruiting60RCT, Double-blindSolbinsiran, Placebo
NCT04469764
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma
P2
Recruiting32Open-labelAbemaciclib, Anastrozole, Letrozole
NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
P2
Recruiting1,431RCT, Double-blindLY4268989, Placebo
NCT07287098
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Breast Neoplasms
P2
Recruiting600RCT, Open-labelImlunestrant, Goserelin, Tamoxifen 20 mg
NCT02981940
A Study of Abemaciclib in Recurrent Glioblastoma
Glioblastoma
P2
Active45Open-labelAbemaciclib
NCT04623541
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
P1P2
Active194Open-labelEpcoritamab, Epcoritamab, rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone, Venetoclax, Epcoritamab, Lenalidomide, Epcoritamab, Pirtobrutinib, Epcoritamab
NCT07219173
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Asthma
P2
Recruiting531RCT, Double-blindBrenipatide, Brenipatide, Placebo
NCT07698210
A Study of LY4178256 in Healthy Participants
Healthy Volunteers
P1
Recruiting88RCT, Double-blindLY4178256, Placebo
NCT07547540
A Study of LY3971297 in Participants With Heart Failure
Heart Failure, Heart Failure, Diastolic
P1
Recruiting90RCT, Single-blindLY3971297, LY3971297, Placebo, Placebo
NCT07787169
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
Alzheimer Disease, Amyloid
P1
Recruiting179RCT, Double-blindLY4405094, LY4405094, Placebo, Placebo
NCT07165002
A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment
Healthy, Hepatic Insufficiency
P1
Recruiting32Open-labelLY3537031
NCT04603001
Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
P1
Active260Open-labelLY3410738, Venetoclax, Azacitidine
NCT06982859
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
Diabetes Mellitus, Insulin Sensitivity
P1
Active95RCT, Double-blindRetatrutide, Semaglutide, Placebo
NCT07566338
A Study of LY4302814 in Healthy Participants
Healthy
P1
Recruiting150RCT, Double-blindLY4302814, LY4302814, Placebo, Placebo
NCT07654972
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Obesity, Overweight
P1
Recruiting116RCT, Double-blindLY4174794, LY4174794, Placebo
NCT07801300
A Study of LY5625575 in Healthy Participants and in Participants With Inflammation (Elevated C-Reactive Protein)
Healthy Volunteers, C-Reactive Protein
P1
Recruiting204RCT, Double-blindLY5625575, Placebo
NCT07476118
A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity
Obesity, Overweight
P1
Active150RCT, Double-blindBrenipatide
NCT06678269
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
Metastatic Breast Cancer, Stage IV Breast Cancer
P1
Recruiting28Open-labelAbemaciclib
NCT06343805
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Primary Myelofibrosis
P1
Recruiting256Open-labelLY5830966
NCT07258849
A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
P1
Recruiting141RCT, Open-labelLY4213663, LY4213663, Placebo, Placebo
NCT07767487
A Study of LY4226695 in Healthy Participants
Healthy
P1
Recruiting148RCT, Double-blindLY4226695, LY4226695, Placebo
NCT00414115
National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children
Adverse Drug Reaction (ADR)
Recruiting7,000——
NCT03958136
Clinico-biological Data Collection Study of Metastatic Breast Cancer
Breast Cancer
N/A
Active289Open-labelBiomarkers blood, urine and microbiota samples
NCT07063316
SGLT2 Inhibitors and Renal Anemia in Japan: RWD
Chronic Kidney Disease
Active15,000—SGLT2 inhibitor
NCT06991946
Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain
Metastatic Breast Cancer
Recruiting300——
NCT03549416
BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
Atopic Dermatitis
Recruiting1,200——
NCT06566170
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Alzheimer Disease
Recruiting6,250—Donanemab, Usual Care
NCT00206375
Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
Hypothyroidism
P4
Terminated16RCT, Open-labelGrowth hormone, Growth hormone treatment and puberty
NCT00422162
A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
Major Depressive Disorder
P4
Completed339RCT, Double-blindDuloxetine hydrochloride, Placebo
NCT00716274
Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia
Attention Deficit Hyperactivity Disorder, Dyslexia
P4
Completed110RCT, Double-blindAtomoxetine, Placebo
NCT00190736
Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)
ADHD
P4
Completed440RCT, Double-blindAtomoxetine Hydrochloride, placebo
NCT00067912
Duloxetine vs. Active Comparator for the Treatment of Depression
Depression
P4
Completed480RCT, Double-blindDuloxetine Hydrochloride, Venlafaxine Extended Release
NCT06901518
The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches
Post-Traumatic Headache
P4
Completed25Open-labelGalcanezumab-Gnlm
NCT00191464
Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P4
Completed320RCT, Open-labelpremeal insulin lispro mixtures, insulin glargine, metformin
NCT00477581
A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
P4
Completed102RCT, Double-blindexenatide, sitagliptin
NCT04271202
Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
Chronic Migraine
P4
Completed64Open-labelEmgality 120 MG in 1 ML Prefilled Syringe
NCT00191399
Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
Depression, Bipolar
P4
Completed150RCT, Open-labelOlanzapine, Fluoxetine
NCT03573323
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
P4
Completed1,027RCT, Double-blindIxekizumab, Guselkumab, Placebo
NCT00100776
Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
Schizophrenia, Schizoaffective Disorder
P4
Completed600RCT, Double-blindOlanzapine
NCT01774968
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
P4
Completed325RCT, Open-labelHuman Regular U-500 Insulin
NCT00870194
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
Type 2 Diabetes Mellitus
P4
Completed255RCT, Double-blindexenatide and sitagliptin, exenatide and placebo
NCT04086745
A Study of Baricitinib in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
P4
Completed1,050RCT, Open-labelBaricitinib, TNF Inhibitor
NCT00485849
A Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD
Attention Deficit Hyperactivity Disorder
P4
Completed12Open-labelAtomoxetine Hydrochloride
NCT05080218
COVID-19 VaccinE Response in Rheumatology Patients
Rheumatoid Arthritis, Psoriatic Arthritis
P4
Completed841RCT, Open-labelUpadacitinib, Abatacept, Secukinumab, Tofacitinib, TNF Inhibitor, Canakinumab Injection, Baricitinib, Ixekizumab
NCT00191178
Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes
Type 2 Diabetes
P4
Completed60RCT, Open-labelinsulin lispro protamine suspension:insulin lispro rDNA origin low mix, insulin glargine
NCT00266643
Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain
Diabetic Neuropathy, Painful
P4
Completed205RCT, Double-blindduloxetine hydrochloride
NCT00188942
A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
Major Depressive Disorder
P4
Completed42Open-labelFluoxetine+Olanzapine, Olanzapine
NCT00216918
Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.
Attention Deficit Hyperactivity Disorder
P4
Completed40Open-labelAtomoxetine Hydrochloride
NCT00191282
Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
Diabetes Mellitus, Type 2, Acute Myocardial Infarction
P4
Completed1,116RCT, Open-labelInsulin lispro, Human insulin isophane suspension (NPH), Insulin glargine, Human insulin isophane suspension, Human insulin 30/70
NCT00488163
Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
Schizophrenia
P4
Completed20RCT, Double-blindAtomoxetine
NCT00252278
Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents
Attention-Deficit/Hyperactivity Disorder (ADHD), Insomnia
P4
Unknown36RCT, Double-blindatomoxetine
NCT01391221
Inflammatory Markers and Cognitive Function in Major Depression
Major Depression
P4
Unknown20Open-labelDuloxetine
NCT01703702
Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
Alzheimer's Disease
P4
Completed641RCT, Open-labelflorbetapir (18F)
NCT00420095
A Study for Patients With Diabetes Mellitus (IOPA)
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
P4
Completed117RCT, Open-labelHuman insulin 30/70, Insulin lispro low mix
NCT00394095
Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine
Bipolar Disorder, Weight Gain
P4
Completed31RCT, Double-blindTopiramate, Placebo
NCT00696293
Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults
Major Depressive Disorder, Back Pain
P4
Completed30Open-labelDuloxetine
NCT00380718
Chemotherapy for Patients With Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
P4
Completed33Open-labelpemetrexed
NCT00960986
A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder
Major Depressive Disorder (MDD)
P4
Completed249RCT, Open-labelDuloxetine hydrochloride
NCT04707196
A Study of Abemaciclib in Indian Women With Advanced Breast Cancer
Breast Neoplasms, Neoplasm Metastasis
P4
Completed200Open-labelAbemaciclib, Nonsteroidal Aromatase Inhibitor (NSAI), Fulvestrant
NCT00485498
Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
Schizophrenia
P4
Completed122RCT, Double-blindOlanzapine Hydrochloride, Risperidone
NCT00169065
Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia
Schizophrenia
P4
Completed38RCT, Single-blindClozapine, Olanzapine
NCT00049777
A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)
Sepsis
P4
Completed2,000RCT, Double-blindDrotrecogin Alfa (Activated), Unfractionated heparin, Low molecular weight heparin
NCT00279201
The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)
Diabetes Mellitus, Type 2
P4
Completed2,091RCT, Open-labelInsulin glargine, Lispro Low Mix, Lispro Mid Mix, Lispro
NCT00440895
A Randomized Trial of Early Discharge After Trans-radial Stenting of Coronary Arteries in Acute MI and Rescue-PCI
Myocardial Infarction, Ischemia
P4
Completed74RCT, Double-blindAbciximab
NCT06635057
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
Type 2 Diabetes
P4
Completed166Open-labelTirzepatide
NCT00532428
Long Term Effects of Raloxifene Treatment on Bone Quality
Osteoporosis, Post-Menopausal
P4
Completed31RCT, Double-blindRaloxifene, Raloxifene, Placebo
NCT01451606
Duloxetine for the Treatment of Chronic Pelvic Pain
Pelvis Pain Chronic
P4
Terminated34RCT, Double-blindDuloxetine, Placebo
NCT02240680
Linagliptin as Add on to Basal Insulin in the Elderly
Diabetes Mellitus, Type 2
P4
Completed302RCT, Double-blindplacebo, linagliptin
NCT00485862
Combination Therapy in Patients With Depression
Depressive Symptoms
P4
Completed214RCT, Double-blindAtomoxetine Hydrochloride, Sertraline, Placebo
NCT00191061
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder
Depressive Disorder
P4
Completed640RCT, Double-blindduloxetine hydrochloride
NCT00239629
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
Postmenopausal Osteoporosis
P4
Completed73RCT, Open-labelTeriparatide, Strontium ranelate
NCT01118780
A Study of Duloxetine in Elderly Generalized Anxiety Disorder
Generalized Anxiety Disorder
P4
Completed291RCT, Double-blindDuloxetine, Placebo
NCT00673452
A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia
Fibromyalgia
P4
Completed530RCT, Double-blindduloxetine hydrochloride, placebo
NCT00181948
Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy
ADHD
P4
Completed30Open-labelatomoxetine (Strattera)
NCT01430104
A Study of Teriparatide in Japanese Osteoporosis Patients
Osteoporosis
P4
Completed30Open-labelTeriparatide, Aspara-CA 600 mg, Alfarol 1.0 µg
NCT00079924
Effects of Teriparatide in Postmenopausal Women With Osteoporosis
Postmenopausal Osteoporosis
P4
Completed200RCT, Open-labelteriparatide, aldrenodate, raloxifene
NCT05002127
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
P2P3
Completed127RCT, Double-blindEvorpacept (ALX148), Trastuzumab, Ramucirumab, Paclitaxel
NCT04809220
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
Diabetes Mellitus, Diabetes Mellitus, Type 2
P3
Completed591RCT, Double-blindDulaglutide, Oral antihyperglycemics
NCT00976456
Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer
Non-squamous Non-small Cell Lung Cancer
P3
Completed271RCT, Open-labelBevacizumab + Pemetrexed, Bevacizumab + Pemetrexed + Carboplatin
NCT01139762
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
Benign Prostatic Hyperplasia, Enlarged Prostate
P3
Completed696RCT, Double-blindTadalafil, Placebo, Finasteride
NCT02132637
A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes
Type 2 Diabetes Mellitus
P3
Completed68RCT, Double-blindInsulin Peglispro, Insulin Glargine
NCT00816959
Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma
Hodgkin's Lymphoma
P3
Unknown1,200RCT, Open-labelR-mabHDI and ABVD, ABVD
NCT03214380
A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes
Type 2 Diabetes Mellitus
P3
Completed933RCT, Double-blindLY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec, Metformin, SGLT2 inhibitor
NCT03524092
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
P3
Completed1,328Double-blindMirikizumab SC, Mirikizumab IV, Placebo SC
NCT02783573
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
Alzheimer's Disease
P3
Terminated1,722RCT, Double-blindLanabecestat, Placebo
NCT00421083
Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury
Erectile Dysfunction, Spinal Cord Injuries
P3
Completed180RCT, Double-blindtadalafil
NCT00190788
Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion
Sepsis, Hypotension
P3
Completed200RCT, Double-blindDrotrecogin Alfa (Activated), placebo
NCT03433677
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
Diabetes Type 1
P3
Completed49RCT, Double-blindLY900014, Insulin lispro
NCT00332202
PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Non Hodgkin Lymphoma
P3
Completed758RCT, Double-blindenzastaurin, placebo
NCT01015287
A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction
Acute Coronary Syndromes
P3
Completed4,033RCT, Double-blindPlacebo, Prasugrel
NCT00970632
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia (BPH)
P3
Completed511RCT, Double-blindTadalafil 5 mg, Placebo tablet, Tamsulosin, Placebo capsule
NCT00485407
Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine
Attention Deficit Hyperactivity Disorder
P3
Completed377RCT, Double-blindAtomoxetine Hydrochloride
NCT02760602
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease
Alzheimer's Disease
P3
Terminated26RCT, Double-blindSolanezumab, Placebo
NCT01177813
Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P3
Completed986RCT, Double-blindPlacebo identical to BI10773 high dose, BI 10773, BI 10773 open label, Placebo identical to BI10773 low dose, Placebo identical to BI10773 low dose, Placebo identical to BI10773 high dose, Placebo identical to Sitagliptin 100mg, Placebo identical to Sitagliptin 100mg, BI10773, Sitagliptin, Placebo identical to Sitagliptin 100mg, Placebo identical to BI10773 low dose, Placebo identical to BI10773 high dose
NCT00359879
Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
Type 2 Diabetes
P3
Completed377RCT, Open-labelexenatide, exenatide
NCT00190996
Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence
Urinary Incontinence, Stress
P3
Completed2,765RCT, Double-blindDuloxetine Hydrochloride, placebo
NCT00191113
Somatropin Treatment to Final Height in Turner Syndrome
Turner Syndrome
P3
Completed154RCT, Open-labelSomatropin, Ethinyl estradiol, Medroxyprogesterone acetate
NCT02528253
A Phase 3 Study of Tanezumab for Chronic Low Back Pain
Low Back Pain
P3
Completed1,832RCT, Double-blindPlacebo to Week 16; tanezumab 5mg SC, Placebo to Week 16, tanezumab 10 mg SC, Tanezumab 5 mg SC, Tanezumab 10 mg SC, Tramadol PR oral
NCT01215942
An Open Label Study for Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
P3
Terminated1,086RCT, Open-labelLY2127399
NCT03926130
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Crohn's Disease
P3
Completed1,158RCT, Double-blindMirikizumab, Mirikizumab, Ustekinumab, Ustekinumab, Placebo, Placebo
NCT00262769
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
Extrahepatic Bile Duct Cancer, Gallbladder Cancer
P3
Completed324RCT, Open-labelcisplatin, gemcitabine hydrochloride
NCT04392154
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Atopic Dermatitis
P3
Completed1,153Double-blindLebrikizumab
NCT01646177
A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)
Psoriasis
P3
Completed1,346RCT, Double-blindPlacebo, 50 mg etanercept, 80 mg ixekizumab
NCT02580591
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
Diabetes Mellitus, Type 1
P3
Completed977RCT, Double-blindEmpagliflozin, Placebo
NCT04146363
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)
Atopic Dermatitis
P3
Completed424RCT, Double-blindLebrikizumab
NCT02696785
A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis
Spondyloarthritis
P3
Completed341RCT, Double-blindIxekizumab, Placebo, Adalimumab
NCT02963766
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
Type 2 Diabetes
P3
Completed154RCT, Double-blindDulaglutide, Placebo
NCT00191529
Growth Hormone Treatment in Short Children Born Small for Gestational Age
Infant, Small for Gestational Age
P3
Completed200RCT, Open-labelsomatropin
NCT01204294
Comprehensive Add on Study in Japan
Diabetes Mellitus, Type 2
P3
Completed574RCT, Open-labelLinagliptin, Linagliptin, Metformin, Metformin, Linagliptin, Linagliptin, Linagliptin
NCT06588296
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
Psoriatic Arthritis, Obesity
P3
Completed279RCT, Open-labelIxekizumab, Tirzepatide
NCT00035035
A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.
Pancreatic Neoplasms, Metastases, Neoplasm
P3
Completed—RCT, Open-labelGEMZAR, ALIMTA
NCT00762411
Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo
Alzheimer's Disease
P3
Completed1,111RCT, Double-blindLY450139, Placebo
NCT01435616
A Study in Patients With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
P3
Completed1,538RCT, Double-blindGlargine, LY2605541
NCT04250337
Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.
Atopic Dermatitis
P3
Completed228RCT, Double-blindLebrikizumab
NCT06584916
A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
Obesity, Overweight
P3
Completed376RCT, Double-blindOrforglipron, Placebo
NCT00996658
Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone
Diabetes Mellitus, Type 2
P3
Completed278RCT, Double-blindPlacebo, Linagliptin
NCT04537923
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
Type 2 Diabetes
P3
Completed1,428RCT, Open-labelTirzepatide, Insulin Lispro (U100)
NCT00191126
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC
Non-Small Cell Lung Cancer
P3
Completed263RCT, Open-labelgemcitabine, Cisplatin
NCT05780268
LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
COVID-19
P3
Completed314RCT, Double-blindLY3819253, Placebo, Remdesivir
NCT00568685
Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder
P3
Completed153RCT, Open-labelAtomoxetine Hydrochloride, Atomoxetine hydrochloride, Atomoxetine hydrochloride
NCT00560417
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide
Diabetes Mellitus, Type 2
P3
Completed339RCT, Open-labelInsulin Lispro Protamine Suspension, Insulin Glargine
NCT02923921
Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer
Pancreatic Cancer
P3
Completed567RCT, Open-labelPegilodecakin, FOLFOX
NCT00676338
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
Type 2 Diabetes Mellitus
P3
Completed820RCT, Double-blindexenatide once weekly, metformin, sitagliptin, pioglitazone
NCT00568737
The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death
Sepsis
P3
Completed2,640RCT, Double-blindDrotrecogin alfa (activated), Placebo
NCT03057951
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Heart Failure
P3
Completed5,988RCT, Double-blindEmpagliflozin, Placebo
NCT01997411
Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
Diabetes Mellitus, Type 1
P2P3
Completed48RCT, Double-blindNasal Glucagon, Intramuscular Glucagon
NCT04591626
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
Type 2 Diabetes Mellitus
P3
Completed291RCT, Double-blindDulaglutide, Placebo, Insulin Glargine
NCT01075282
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
Diabetes Mellitus, Type 2
P3
Completed810RCT, Open-labelInsulin Glargine, LY2189265, Metformin, Glimepiride
NCT05024032
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
Obesity, Overweight
P3
Completed210RCT, Double-blindTirzepatide, Placebo
NCT00191152
A Phase III Trial For Patients With Metastatic Breast Cancer
Breast Cancer, Breast Neoplasms
P3
Completed475RCT, Open-labelgemcitabine, docetaxel, capecitabine
NCT00489073
Duloxetine Versus Placebo for Fibromyalgia
Fibromyalgia
P3
Completed345RCT, Double-blindduloxetine, placebo
NCT03334396
A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
P3
Completed660RCT, Double-blindBaricitinib, Placebo
NCT00543218
PTH Comparison in Post Menopausal Women
Osteoporosis, Post-Menopausal
P3
Completed63RCT, Open-labelteriparatide 20 micrograms/day subcutaneous, calcitonin 100 IU/day subcutaneous
NCT01005680
A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer
Non Small Cell Lung Cancer
P3
Completed256RCT, Open-labelPemetrexed, Gemcitabine, Cisplatin
NCT00191880
Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder
P3
Completed100Open-labelatomoxetine
NCT00920582
Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
P3
Terminated254RCT, Double-blindTeplizumab Herold Regimen, Placebo, Teplizumab 33.3% Herold Regimen, Teplizumab Curtailed Herold Regimen
NCT00577824
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
Type 2 Diabetes
P3
Completed181RCT, Double-blindexenatide, exenatide, placebo
NCT00638638
Myocardial Infarction With ST-Elevation
Myocardial Infarction
P3
Unknown292RCT, Double-blindAbciximab, Abciximab placebo
NCT01003184
Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus
P3
Completed222RCT, Open-labelexenatide once weekly, insulin detemir
NCT00391209
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
P3
Completed379RCT, Open-labelsimplified diabetes regimen starting with a fixed dose of Human Insulin Inhalation Powder, intensive diabetes management starting with an adjusted dose of Human Insulin Inhalation Powder
NCT00785421
Chemotherapy With or Without Enoxaparin in Pancreatic Cancer
Pancreatic Cancer
P2P3
Completed312RCT, Open-labelenoxaparin, chemotherapy with LMWH - enoxaparin, only chemotherapy
NCT00146276
Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer
Bladder Cancer, Carcinoma, Transitional Cell
P3
Unknown178RCT, Open-labelgemcitabine
NCT04517253
A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS
Nakajo-Nishimura Syndrome, Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature Syndrome
P2P3
Terminated10Open-labelBaricitinib
NCT01198002
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
Rheumatoid Arthritis
P3
Terminated1,041RCT, Double-blindLY2127399, Placebo Q2W, Placebo Q4W, Methotrexate
NCT01202773
A Study in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
P3
Terminated456RCT, Double-blindLY2127399, Placebo Q4W, Placebo Q2W
NCT02008318
A Study of Galunisertib in Participants With Myelodysplastic Syndromes
Myelodysplastic Syndromes
P2P3
Completed43Open-labelGalunisertib, Placebo
NCT00034268
A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
P3
Completed—RCT, Open-labelLY900003
NCT01159600
Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P3
Completed1,504RCT, Double-blindPlacebo identical to BI 10773 high dose, Placebo identical to BI 10773 low dose, BI 10773, BI 10773, Placebo identical to BI 10773 low dose, BI 10773, Placebo identical to BI 10773 high dose
NCT00577863
Study of the Experience of Patients With Osteoporosis Using the Forteo B Pen to Self Administer Once Daily Teriparatide Therapy
Osteoporosis
P3
Completed200Open-labelteriparatide
NCT01164501
Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment
Diabetes Mellitus, Type 2, Renal Insufficiency
P3
Completed741RCT, Double-blindBI 10773, Placebo, Placebo, BI 10773, Placebo, Placebo
NCT00279175
REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI)
Myocardial Infarction
P3
Completed204RCT, Double-blindIntracoronary infusion of enriched bone marrow-derived progenitor cells, Placebo medium supplemented with autologous serum
NCT00126139
Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis
Stroke, Stenosis
P3
Terminated100RCT, Double-blindAbciximab
NCT00552175
A Study for the Treatment of Diabetic Peripheral Neuropathic Pain
Diabetic Neuropathies
P3
Completed339RCT, Double-blindDuloxetine hydrochloride - 40 mg, placebo, Duloxetine hydrochloride - 60 mg
NCT03535194
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Psoriasis
P3
Completed1,484RCT, Double-blindMirikizumab, Placebo, Secukinumab
NCT04285229
A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis
Spondyloarthritis
P3
Completed147RCT, Double-blindIxekizumab, Placebo
NCT00989157
Effects of Gastric Bypass on Blood Levels of Duloxetine
Bariatric Surgery
P3
Completed20Open-labelDuloxetine
NCT00383422
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
Osteoporosis, Postmenopausal
P3
Completed320RCT, Double-blindArzoxifene, Raloxifene
NCT00485901
Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia
Schizophrenia
P3
Completed50RCT, Double-blindOlanzapine Hydrochloride, Haloperidol
NCT00384930
Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
P2P3
Completed1,058RCT, Double-blindtadalafil, tadalafil, tadalafil, tadalafil, placebo
NCT01087502
Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment
Diabetes Mellitus, Type 2
P3
Completed241RCT, Double-blindGlimepiride, Placebo, Placebo, Placebo, Linagliptin
NCT00568672
Optimal Duration of Olanzapine Add-on Therapy in Major Depression
Relapse Rate of a Major Depressive Episode, Safety of Olanzapine in Subjects With Major Depression
P3
Withdrawn—RCT, Double-blindOlanzapine
NCT00191100
Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix
Cancer of Cervix
P3
Completed515RCT, Open-labelGemcitabine, Cisplatin
NCT01794000
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
Sickle Cell Disease
P3
Terminated341RCT, Double-blindPrasugrel, Placebo
NCT01937871
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)
Benign Prostate Hyperplasia, Erectile Dysfunction
P3
Completed909RCT, Double-blind5 mg Tadalafil, Placebo, 0.2 mg Tamsulosin
NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Obesity
P3
Not Yet Recruiting2,115RCT, Double-blindeloralintide and tirzepatide, Eloralintide, Tirzepatide, Placebo
NCT00827242
Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily
Benign Prostatic Hyperplasia
P3
Completed325RCT, Double-blindPlacebo, tadalafil
NCT01289990
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P3
Completed2,705Double-blindBI 10773, Placebo, Placebo, Placebo, Placebo, Placebo, BI 10773, Placebo, Placebo, BI 10773, Placebo, Placebo, Placebo, BI 10773, BI 10773, BI 10773, Placebo, BI 10773, Placebo, Placebo, Placebo, Sitagliptin 100mg, BI 10773, Placebo, Placebo, Placebo, Placebo, Placebo, Placebo, Placebo
NCT03421379
A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus
Diabetes Mellitus
P3
Completed75RCT, Open-labelGlucagon Nasal Powder, Glucagon Hydrochloride Solution
NCT00121446
Which Therapy for Acute Heart Attacks? (The WEST Study)
Myocardial Infarction
P2P3
Completed300RCT, Open-labeltenecteplase, enoxaparin, clopidogrel
NCT05074420
A Study of Baricitinib (LY3009104) in Children With COVID-19
Covid19, Corona Virus Infection
P3
Terminated6Open-labelBaricitinib
NCT00547183
Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection
Impotence
P3
Completed298RCT, Double-blindtadalafil, tadalafil, placebo
NCT04421027
A Study of Baricitinib (LY3009104) in Participants With COVID-19
COVID-19
P3
Completed1,525RCT, Double-blindBaricitinib, Placebo
NCT01185340
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
Major Depressive Disorder
P3
Completed1,056RCT, Double-blindLY2216684, Placebo, SSRI
NCT06010004
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Type 2 Diabetes
P3
Completed401RCT, Open-labelOrforglipron
NCT03861039
A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
Type 2 Diabetes Mellitus
P3
Completed443RCT, Open-labelTirzepatide, Oral antihyperglycemic medication (OAM)
NCT04250350
Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
P3
Completed206Open-labelLebrikizumab
NCT00747968
The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
Type 2 Diabetes
P2P3
Completed8RCT, Double-blindByetta, Exenatide
NCT00485550
Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy
Attention Deficit Hyperactivity Disorder
P3
Completed14RCT, Double-blindAtomoxetine Hydrochloride, Methylphenidate Hydrochloride, Placebo
NCT00734474
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
Diabetes Mellitus, Type 2
P2P3
Completed1,202RCT, Double-blindLY2189265, Sitagliptin, Placebo solution, Placebo tablet, Metformin
NCT00190710
A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer
Non-Small Cell Lung Cancer
P3
Completed242RCT, Open-labelGemcitabine, Carboplatin
NCT01131676
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).
Diabetes Mellitus, Type 2
P3
Completed7,064RCT, Double-blindBI 10773 low dose, Placebo BI 10773 high dose, BI 10773 high dose, Placebo BI 10773 low dose, Placebo BI 10773 low dose, Placebo BI 10773 high dose
NCT01205438
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus, Connective Tissue Disease
P3
Completed1,124RCT, Double-blindLY2127399, Placebo every 2 weeks, Placebo every 4 weeks
NCT01422876
Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients
Diabetes Mellitus, Type 2
P3
Completed1,405RCT, Double-blindhigh dose FDC, BI 10773 high dose, high dose FDC placebo, low dose FDC placebo, high dose FDC placebo, high dose FDC placebo, low dose FDC placebo, low dose FDC placebo, high dose BI 10773 placebo, low dose FDC, high dose FDC placebo, BI 10773 low dose, high dose BI 10773 placebo, high dose BI 10773 placebo, linagliptin, low dose FDC placebo, linagliptin placebo, BI 10773 low dose placebo, linagliptin placebo, low dose BI 10773 placebo, linagliptin placebo, high dose BI 10773 placebo, BI 10773 low dose placebo, low dose BI 10773 placebo, linagliptin placebo
NCT03952143
A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes
Type 2 Diabetes Mellitus
P3
Completed628RCT, Double-blindLY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec
NCT02453555
Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
P3
Completed275RCT, Double-blindLinagliptin, Empagliflozin placebo + linagliptin placebo low dose, Empagliflozin + linagliptin low dose, Linagliptin placebo, Empagliflozin + linagliptin high dose, Empa + lina highdose placebo
NCT00122824
Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder
Anxiety Disorders
P3
Completed480RCT, Double-blindduloxetine hydrochloride, placebo
NCT00917267
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
Type 2 Diabetes Mellitus
P3
Completed691RCT, Open-labelexenatide once weekly, exenatide twice daily
NCT00077233
FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum
Colorectal Cancer
P3
Terminated238RCT, Open-labelcetuximab, 5-FU, irinotecan, leucovorin, oxaliplatin
NCT03670810
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
Migraine
P3
Completed1,633RCT, Double-blindLasmiditan, Placebo
NCT00051298
Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia
Schizophrenia
P3
Completed107RCT, Double-blindOlanzapine, Placebo
NCT01167023
Prasugrel Versus Placebo in Adult Sickle Cell Disease
Sickle Cell Anemia
P2
Completed62RCT, Double-blindPrasugrel, Placebo
NCT00103935
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
Type 2 Diabetes Mellitus
P2
Completed45RCT, Double-blindplacebo, placebo, Exenatide LAR, Exenatide LAR
NCT00384774
A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine
Migraine
P2
Completed130RCT, Double-blindLasmiditan, Placebo
NCT00202800
Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Pancreatic Cancer
P2
Completed40Single-blindGemcitabine, Etoposide
NCT01774981
Study of LY3016859 in Participants With Diabetic Nephropathy
Diabetic Nephropathy
P1P2
Completed60RCT, Double-blindPlacebo, LY3016859
NCT04493502
A Study of LY3041658 in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
P2
Completed72RCT, Double-blindPlacebo, LY3041658
NCT04640077
A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)
Alzheimer Disease, Dementia
P2
Completed95Open-labeldonanemab
NCT06074562
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathy
P2
Completed404RCT, Double-blindMazisotine, Placebo
NCT00409006
Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers
Non-small Cell Lung Cancer
P2
Completed70RCT, Open-labelPemetrexed, Cisplatin, Gefitinib
NCT00149214
Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens
Breast Cancer
P2
Completed257RCT, Open-labelpemetrexed, cyclophosphamide, doxorubicin, docetaxel
NCT01408095
A Study in Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P2
Withdrawn240RCT, Double-blindLY2608204, Glimepiride
NCT00192075
A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer
Colorectal Cancer
P2
Completed84RCT, Open-labelGemcitabine, avastin, 5FU/folinic acid, oxaliplatin
NCT00383292
A Study of Tasisulam in Treating Participants With Malignant Melanoma
Metastatic Melanoma
P2
Completed130Open-labeltasisulam
NCT00370292
Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
P2
Completed19Open-labelPemetrexed - Before Protocol Amendment, Pemetrexed - After Protocol Amendment
NCT01113801
A Study in Participants With Diabetic Kidney Disease
Diabetic Kidney Disease, Diabetic Nephropathy
P2
Terminated417RCT, Double-blindLY2382770, Placebo
NCT00201760
Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
Breast Cancer
P2
Completed10RCT, Open-labelGemcitabine, Trastuzumab, Cisplatin
NCT00280150
Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
Lung Cancer
P1P2
Completed46Open-labelbevacizumab, carboplatin, erlotinib hydrochloride, paclitaxel
NCT04585776
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
Type 1 Diabetes
P2
Completed31Open-labelLY900014, Insulin Degludec
NCT05256654
A Study of LY3561774 in Participants With Mixed Dyslipidemia
Dyslipidemias, Lipid Metabolism Disorders
P2
Completed205RCT, Double-blindLY3561774, Placebo
NCT00063388
Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer
Non-Small-Cell Lung Cancer
P2
Completed66Open-labelCetuximab
NCT00215930
The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
P2
Completed53Open-labelVinorelbine, Docetaxel, Gemcitabine, Carboplatin
NCT00102219
A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer
Breast Cancer
P2
Completed77Open-labelPemetrexed, Doxorubicin
NCT00538681
Study for Participants With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo
Lung Cancer
P2
Terminated35RCT, Double-blindenzastaurin, pemetrexed, cisplatin, placebo
NCT05611671
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Inflammatory Bowel Diseases, Colitis, Ulcerative
P2
Completed280RCT, Double-blindMORF-057, Placebo
NCT00527111
Pre-op Rectal ChemoRad +/- Cetuximab
Rectal Cancer
P2
Completed139RCT, Open-labelCetuximab, 5-fluorouracil
NCT00450762
Gemcitabine + Carboplatin in Breast Cancer
Breast Cancer
P2
Completed—Open-labelgemcitabine, carboplatin
NCT01763788
A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
Squamous Non-small Cell Lung Cancer
P1P2
Completed192RCT, Open-labelNecitumumab, Gemcitabine, Cisplatin
NCT00456261
First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
Lung Cancer
P2
Completed110RCT, Open-labelPemetrexed, Gemcitabine, Bevacizumab, Carboplatin
NCT00191373
A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease
Breast Neoplasms, Cancer of the Breast
P2
Completed66Open-labelGemcitabine, Trastuzumab
NCT00913835
A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer
Ovarian Neoplasms
P2
Completed125RCT, Open-labelOlaratumab, liposomal doxorubicin
NCT00466440
A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients
Prostate Cancer
P2
Completed108RCT, Double-blindenzastaurin, placebo, docetaxel, prednisone
NCT00617201
Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
Substance Abuse
P2
Completed50RCT, Double-blindatomoxetine, placebo
NCT01193218
Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
P2
Completed547RCT, Double-blindPlacebo (low dose), Placebo (low dose), Placebo (mid dose), Placebo (high dose), BI 10773, Placebo (mid dose), Placebo (high dose), Placebo (high dose), BI 10773, BI 10773, Placebo (mid dose), Placebo (high dose), Placebo (low dose), Placebo (low dose), BI 10773, Placebo (mid dose)
NCT03137160
An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
Pyoderma Gangrenosum
P2
Completed4Open-labelIxekizumab
NCT00190671
A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients
Breast Cancer
P1P2
Completed103RCT, Open-labelpemetrexed, cyclophosphamide, pemetrexed
NCT01027871
A Study for Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P2
Completed289RCT, Open-labelLY2605541, insulin glargine
NCT01107444
Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
P2
Completed180RCT, Open-labelDocetaxel, LY2181308
NCT00759772
The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa
Anorexia Nervosa, Osteoporosis
P2
Completed23RCT, Single-blindPlacebo, Teriparatide
NCT00116519
A Study in People With Abnormal Fat Levels in the Blood
Dyslipidemia
P2
Completed300RCT, Double-blindPPAR alpha, placebo
NCT00115635
Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer
Prostate Cancer
P1P2
Completed60Open-labeldocetaxel, gemcitabine
NCT02659020
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
Soft Tissue Sarcoma
P1P2
Completed310RCT, Double-blindOlaratumab, Gemcitabine, Docetaxel, Placebo
NCT00515697
A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
P2
Completed39Open-labelRamucirumab
NCT00316238
A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia
Schizophrenia
P2
Completed160RCT, Double-blindolanzapine-RAIM, placebo
NCT00332553
Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
Vasomotor Symptoms, Endometrial Safety
P2
Completed150RCT, Double-blindRaloxifene, medroxyprogesterone acetate, estrogen, 17 beta estradiol
NCT00768131
A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel
Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
P2
Withdrawn—RCT, Open-labelCetuximab, Paclitaxel, Carboplatin
NCT04158700
A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer
Advanced Cancer
P1P2
Withdrawn—Open-labelLY3200882, Pembrolizumab
NCT00533429
Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy
Non-small Cell Lung Cancer
P2
Completed40RCT, Double-blindenzastaurin, pemetrexed, carboplatin, bevacizumab, Placebo
NCT00106002
Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer
Breast Cancer, Breast Neoplasms, Male
P2
Completed37Open-labelpemetrexed
NCT00418093
Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma
Ovarian Cancer, Fallopian Tube Cancer
P2
Terminated19Open-labelGemcitabine, Oxaliplatin, Bevacizumab
NCT02102490
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
Metastatic Breast Cancer
P2
Completed132Open-labelAbemaciclib
NCT00523640
A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma
Carcinoma, Renal Cell
P2
Terminated30Open-labelcombination of gemcitabine, capecitabine, and bevacizumab
NCT01703091
A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer Metastatic
P2
Completed197RCT, Double-blindRamucirumab, Placebo, Docetaxel
NCT00259285
Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer
Non-Small-Cell Lung Cancer
P2
Terminated10Open-labelpemetrexed, cisplatin
NCT00862784
A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer
Colorectal Carcinoma
P2
Completed48Open-labelIMC-1121B (ramucirumab), Oxaliplatin, Folinic acid, 5-FU, 5-FU
NCT02431052
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
Acne Vulgaris
P2
Completed420RCT, Double-blindOlumacostat Glasaretil
NCT00034593
A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
Urologic Neoplasms
P2
Completed——ALIMTA, gemcitabine
NCT00216164
Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Lymphoma, B-Cell
P2
Terminated8Open-labelRituximab, Gemcitabine
NCT05080660
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis
Osteoarthritis, Osteo Arthritis Knee
P2
Completed160RCT, Double-blindLY3526318, Placebo
NCT01011868
Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P2
Completed494RCT, Double-blindBI 10773 placebo, BI 10773 low dose, BI 10773 high dose, BI 10773 placebo
NCT00906282
Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
Non Small Cell Lung Cancer
P2
Completed46Open-labelPemetrexed, Carboplatin
NCT03370276
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx
P1P2
Completed95Open-labelNivolumab, Cetuximab
NCT07548450
Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
Waldenstrom Macroglobulinemia
P2
Not Yet Recruiting25Open-labelPirtobrutinib, Mosunetuzumab
NCT02981342
A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
P2
Completed106RCT, Open-labelAbemaciclib, LY3023414, Gemcitabine, Capecitabine
NCT03831191
A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
P2
Terminated136RCT, Double-blindLY3375880, Placebo
NCT00721162
Study of Ramucirumab in Ovarian Cancer
Ovarian Cancer, Fallopian Tube Cancer
P2
Completed60Open-labelRamucirumab
NCT00400803
Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
P2
Completed38Open-labelGemcitabine, Carboplatin, Bevacizumab
NCT00051909
Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease
Alzheimer's Disease
P2
Completed200RCT, Double-blindLY451395
NCT00368849
Atomoxetine and Huntington's Disease
Huntington Disease, Chorea
P2
Completed20RCT, Double-blindatomoxetine, Matching Placebo
NCT00529204
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
Diabetes Complications, Fatty Liver
P2
Terminated1Open-labelexenatide
NCT01025284
A Study for Participants With Small-Cell Lung Cancer
Small Cell Lung Cancer
P2
Completed64Open-labelLY2523355, Granulocyte colony-stimulating factor (G-CSF)
NCT00061464
Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.
Carcinoma, Non-Small-Cell Lung
P2
Completed48Open-labelpemetrexed, gemcitabine
NCT00192114
Enzastaurin for Patients With Metastatic Colorectal Cancer
Colonic Neoplasms
P2
Completed28Open-labelEnzastaurin HCl
NCT05063539
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
Alzheimer Disease
P2
Completed327RCT, Double-blindLY3372689, LY3372689, Placebo
NCT00402883
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Lung Cancer
P2
Terminated5Open-labelBevacizumab, Pemetrexed, carboplatin
NCT00540124
Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men
Benign Prostatic Hyperplasia
P2
Completed151RCT, Double-blindTadalafil, Placebo, Tamsulosin
NCT00942188
A Study of LY2189102 in Patients With Type 2 Diabetes
Type 2 Diabetes
P2
Completed106RCT, Double-blindLY2189102, Placebo
NCT01160744
A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
P2
Completed280RCT, Open-labelIMC-1121B (ramucirumab), Pemetrexed, Carboplatin (AUC 6), Cisplatin, Gemcitabine, Carboplatin (AUC 5)
NCT00966875
A Study in Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
P2
Completed448RCT, Double-blindLY2439821, Placebo
NCT00063128
Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.
Diabetes Mellitus, Type 1
P2
Completed119RCT, Open-labelinsulin, human insulin inhalation powder (HIIP)
NCT00491075
Pemetrexed Plus Gemcitabine in Renal Cell Cancer
Renal Cell Carcinoma
P2
Terminated16Open-labelPemetrexed, Gemcitabine
NCT00950365
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer
Bronchioloalveolar Carcinoma, Large Cell Lung Carcinoma
P2
Completed79RCT, Open-labelErlotinib Hydrochloride, Pemetrexed Disodium
NCT00222729
Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer
Cancer
P2
Completed42Open-labelPemetrexed, Bevacizumab
NCT00957853
Preoperative Treatment With Cetuximab and/or IMC-A12
Head and Neck Squamous Cell Carcinoma
P2
Completed16RCT, Open-labelCetuximab, IMC-A12
NCT00034541
Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
P1P2
Completed32Open-labelcetuximab, paclitaxel, carboplatin
NCT03086369
A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer
Metastatic Pancreatic Cancer
P1P2
Completed184RCT, Double-blindOlaratumab, Nab-paclitaxel, Gemcitabine, Placebo
NCT01029795
A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
P2
Terminated38RCT, Double-blindLY2599506, Glyburide, Placebo
NCT00542919
A Study for Patients With Non-Hodgkin's Lymphomas
T-Cell Lymphoma, B-Cell Lymphoma
P2
Completed57Open-labelenzastaurin
NCT00061451
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial
Carcinoma, Non-Small-Cell Lung
P2
Completed48Open-labelPemetrexed, Gemcitabine
NCT06124807
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Obesity, Overweight and Obesity
P2
Completed179RCT, Double-blindMazdutide, Placebo
NCT01001104
A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
P2
Completed145RCT, Double-blindLY2189265, Placebo
NCT00099333
Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
Type 2 Diabetes Mellitus
P2
Completed49RCT, Open-labelexenatide, Insulin
NCT00191984
A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
P2
Completed46Open-labelpemetrexed, irinotecan
NCT04032080
LY3023414 and Prexasertib in Metastatic Triple-negative Breast Cancer
Triple Negative Breast Cancer
P2
Completed10Open-label—
NCT02443883
A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
P2
Completed164RCT, Open-labelRamucirumab
NCT04417361
Galcanezumab for Vestibular Migraine
Vestibular Migraine
P2
Completed40RCT, Double-blindGalcanezumab Prefilled Syringe, Placebo
NCT00455442
A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain
Weight-Gain Prevention
P2
Completed57RCT, Double-blindMifepristone
NCT03742973
A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA
Primary Biliary Cholangitis
P2
Terminated2RCT, Double-blindBaricitinib, Placebo
NCT00436280
Chemotherapy for Participants With Lymphoma
Lymphoma, Large Cell, Diffuse
P2
Completed68Open-labelenzastaurin, gemcitabine, rituximab, oxaliplatin
NCT00112346
Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Non-Small-Cell Lung Carcinoma
P2
Completed120RCT, Open-labelCetuximab + platinum + gemcitabine, Platinum + Gemcitabine
NCT01000480
A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer
Non Small Cell Lung Cancer
P2
Completed90Open-labelPemetrexed, Cisplatin
NCT00804570
A Study for the Treatment of Alcohol Dependence
Alcohol Dependence
P2
Completed375RCT, Double-blindLY2196044, placebo
NCT05086289
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain
Chronic Low-back Pain
P2
Completed159RCT, Double-blindLY3526318, Placebo
NCT00420004
A Study for Participants With Major Depression
Major Depressive Disorder
P2
Completed469RCT, Double-blindLY2216684, Placebo, Escitalopram
NCT07085468
A Study of LY3549492 in Healthy Weight Adult Participants
Healthy
P2
Terminated1RCT, Double-blindLY3549492, Placebo
NCT07030868
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Obesity, Overweight
P2
Terminated1RCT, Double-blindLY3549492, Placebo
NCT00162110
A Trial of Erbitux for Recurrent and Metastatic Mucinous Gastrointestinal Adenocarcinoma Involving the Peritoneal Surfaces
Mucinous Gastrointestinal Adenocarcinoma
P2
Completed40Open-labelcetuximab
NCT00609518
A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer
Non Small Cell Lung Cancer
P2
Completed111RCT, Open-labelpemetrexed, dexamethasone, dexamethasone
NCT00329082
Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers
Alzheimer's Disease
P2
Completed25RCT, Double-blindLY2062430, Placebo
NCT02791191
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Alzheimer's Disease
P2
Terminated316RCT, Double-blindLY3202626, Placebo
NCT00451178
A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only
Lymphoma
P2
Completed101RCT, Open-labelenzastaurin, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone
NCT03470350
Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer
Colorectal Cancer Metastatic
P1P2
Withdrawn—Open-labelGalunisertib
NCT02443337
A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
Non-small Cell Lung Cancer Metastatic
P2
Terminated31Open-labelLY3023414, Necitumumab
NCT00623974
Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
Hypocalcemia
P2
Terminated7RCT, Open-labelTeriparatide (Forteo), Calcium, Calcitriol
NCT04031872
LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)
Colorectal Cancer Metastatic
P1P2
Withdrawn—Open-labelLY3200882
NCT00797472
Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
Hodgkin's Disease
P2
Unknown120RCT, Open-labelR-mabHD, ABVD
NCT06568042
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
Neuropathic Pain, Distal Sensory Polyneuropathy
P2
Completed558RCT, Double-blindLY3848575, Placebo
NCT00191308
Molecular Profiling in Lung Cancer Patients
Non-Small Cell Lung Cancer, Carcinoma
P2
Completed30Open-labelpemetrexed, cisplatin
NCT04849416
A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)
Leukemia, Lymphoid, Lymphoma, Non-Hodgkin
P2
Completed87Open-labelLOXO-305
NCT07920887
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
P2
Not Yet Recruiting540RCT, Double-blindBimagrumab, Placebo
NCT03764774
A Study of LY3463251 in Healthy Participants
Healthy
P1
Terminated118RCT, Double-blindLY3463251, Placebo
NCT01408888
A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
P1
Completed29RCT, Open-labelLY2189265, Sitagliptin
NCT06690996
A Study of LY4005130 in Healthy Participants
Healthy
P1
Completed110RCT, Double-blindLY4005130, LY4005130, Placebo, Placebo
NCT01991483
A Study of LY2928057 in Hemodialysis Participants
Renal Insufficiency, Chronic, Kidney Disease, Chronic
P1
Completed28RCT, Double-blindLY2928057, Placebo
NCT06991179
A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants
Healthy
P1
Completed36RCT, Open-labelLY4064809
NCT05515601
A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants
Healthy
P1
Completed396RCT, Single-blindMirikizumab
NCT05086445
A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
P1
Completed62RCT, Double-blindLY3502970, Placebo
NCT01275157
Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects
Healthy Volunteers
P1
Completed6Open-labelLY2452473
NCT01736241
A Study of LY3053102 in Healthy Participants
Healthy Volunteers
P1
Completed41RCT, Double-blindLY3053102, Placebo
NCT06023095
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
Overweight, Obesity
P1
Completed24RCT, Double-blindLY3502970, Placebo
NCT03944031
A Study of the Effects of LY3372689 on the Brain in Healthy Participants
Healthy
P1
Completed17Open-labelLY3372689
NCT03341312
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)
Diabetes Mellitus, Type 2
P1
Completed36RCT, Double-blindLY900014, Insulin Lispro
NCT01784614
A Study of LY2624803 in Japanese Participants With Transient Insomnia
Sleep Initiation and Maintenance Disorders
P1
Completed24RCT, Double-blindLY2624803 - Solution, LY2624803 - Capsule, Placebo - Solution, Placebo - Capsule
NCT00369629
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
Lymphoma
P1
Terminated14Open-labelGemcitabine, Pemetrexed
NCT02718911
A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors
Solid Tumor
P1
Completed72Open-labelLY3022855, Durvalumab, Tremelimumab
NCT03406260
A Study of Lasmiditan in Healthy Elderly Participants
Healthy
P1
Completed36RCT, Double-blindLasmiditan, Placebo
NCT02951780
A Study of LY3185643 and rGlucagon in Healthy Participants
Healthy
P1
Completed23RCT, Double-blindLY3185643, rGlucagon
NCT07439250
A Study of Olomorasib (LY3537982) in Healthy Participants
Healthy
P1
Completed15Open-labelOlomorasib, Fluconazole
NCT04081324
A Study of Lasmiditan in Healthy Chinese Participants
Healthy
P1
Completed36RCT, Double-blindLasmiditan, Placebo
NCT04071262
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer
Advanced Cancer
P1
Completed6Open-labelAbemaciclib, Abiraterone Acetate, Prednisolone
NCT06052462
A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants
Healthy
P1
Completed7Open-label[14C]-LY3556050
NCT03495323
A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors
Cancer
P1
Completed17Open-labelLY3300054, Prexasertib
NCT02588950
A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
P1
Terminated11RCT, Open-labelU-500R
NCT04194892
A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants
Healthy Adult Subjects
P1
Completed12RCT, Open-labelPegilodecakin
NCT05134337
Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants
Healthy Volunteers
P1
Completed27Open-labelLOXO-305, Itraconazole, Rifampin
NCT02317575
A Study of LY900014 Formulations in Healthy Participants
Healthy Volunteers
P1
Completed29RCT, Double-blindLY900014, Insulin Lispro
NCT02242981
A Study of How the Body Breaks Down and Eliminates LY2623091
Healthy Volunteers
P1
Completed6Open-labelLY2623091
NCT00052273
LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors
Adult, Solid Tumor
P1
Completed16—capecitabine, enzastaurin hydrochloride
NCT01632566
A Multiple-dose Study of LY3031207 in Healthy Participants
Healthy Volunteers
P1
Terminated39RCT, Double-blindPlacebo, LY3031207, Celecoxib, Simvastatin
NCT01695005
A Study of LY3039478 in Participants With Advanced Cancer
Neoplasms, Neoplasm Metastasis
P1
Completed247Open-labelLY3039478, Prednisone
NCT07867340
A Study of Single and Multiple Doses of LY5625573 in Healthy Participants, Including Japanese and Chinese Populations, and Participants With Inflammation (High C-Reactive Protein)
C-Reactive Protein
P1
Not Yet Recruiting96RCT, Double-blindLY5625573, Midazolam, Placebo
NCT03977974
A Study of LY3526318 in Healthy Participants
Healthy
P1
Terminated76RCT, Double-blindLY3526318, Placebo
NCT04161976
A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus
Diabetes Mellitus, Type 1
P1
Completed20RCT, Double-blindLY900027, Insulin Lispro
NCT01779830
A Study of LY2624803 in Participants With Transient Insomnia
Transient Insomnia
P1
Completed32RCT, Double-blindLY2624803 - Capsules, Zolpidem - Tablets, Placebo - Capsules, Placebo - Tablets
NCT06869018
A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants
Healthy, Type 2 Diabetes Mellitus (T2D)
P1
Completed92RCT, Double-blindLY3549492, Placebo
NCT03259490
This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood
Healthy
P1
Completed30RCT, Open-labelEmpagliflozin/linagliptin/metformin HCl, Empagliflozin, Linagliptin, Metformin HCl
NCT02123459
A Study of Cephalexin Suspension in Healthy Participants
Healthy Volunteers
P1
Completed28RCT, Open-labelCephalexin
NCT03182920
A Study of Lasmiditan in Healthy Participants
Healthy
P1
Completed35RCT, Double-blindLasmiditan, Placebo
NCT00415636
Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer
Cancer
P1
Completed31Open-labelIC83/LY2603618, IC83/LY2603618, IC83/LY2603618, IC83/LY2603618, IC83/LY2603618, pemetrexed, pemetrexed
NCT02993471
A Study of Ixekizumab in Participants With Plaque Psoriasis
Psoriasis
P1
Completed28Open-labelDrug Cocktail, Ixekizumab
NCT05395481
A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
P1
Completed115RCT, Double-blindLY3849891, Placebo
NCT02688088
A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body
Neoplasm Metastasis
P1
Completed48Open-labelDrug Cocktail, Abemaciclib
NCT03718884
A Study of Mirikizumab in Participants With Plaque Psoriasis
Psoriasis
P1
Completed29Open-labelDrug Cocktail, Mirikizumab
NCT01746732
A Study of Evacetrapib in Healthy Female Participants
Healthy Volunteers
P1
Completed23RCT, Open-labelOrtho-Cyclen, Evacetrapib
NCT01640249
A Study of LY3006072 in Healthy Participants
Healthy Volunteers
P1
Terminated18RCT, Double-blindPlacebo, LY3006072
NCT05533411
A Study of Donanemab (LY3002813) in Healthy Chinese Participants
Healthy
P1
Completed36RCT, Double-blindDonanemab, Placebo
NCT03375463
A Study of Tirzepatide (LY3298176) in Healthy Participants
Healthy
P1
Completed52RCT, Double-blindTirzepatide, Tirzepatide, Placebo, Tirzepatide
NCT03343587
A Study of LY3375880 in Healthy Participants
Healthy
P1
Completed80RCT, Double-blindLY3375880 IV, LY3375880 SC, Placebo IV, Placebo SC
NCT03545087
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
Renal Insufficiency
P1
Withdrawn—Open-labelLanabecestat, Iohexol
NCT01591317
Study of Prasugrel in Korean Healthy Male Volunteers
Healthy Volunteers
P1
Completed30RCT, Open-labelPrasugrel
NCT01742078
A Study of LY2541546 in Healthy Postmenopausal Women
Healthy
P1
Completed60RCT, Double-blindLY2541546 - IV, LY2541546 - SC, Placebo
NCT01742091
A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women
Healthy
P1
Completed59RCT, Double-blindLY2541546 - SC, LY2541546 - IV, Placebo - SC, Placebo - IV
NCT01358968
A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine
Cancer
P1
Completed20Open-labelLY2603618, Desipramine, Pemetrexed, Gemcitabine
NCT02779738
A Study of Merestinib (LY2801653) in Healthy Participants
Healthy
P1
Completed24RCT, Open-labelMerestinib
NCT02576951
A Study of Galcanezumab in Healthy Participants
Healthy
P1
Completed178RCT, Double-blindGalcanezumab, Placebo
NCT06908707
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE102 in Postmenopausal Women
Postmenopausal, Healthy Adult Female Participants
P1
Completed32RCT, Double-blindLAE102 SC, Placebo SC, LAE102 IV, Placebo IV
NCT01275144
A Study of the Effect of LY2216684 on Lorazepam
Major Depressive Disorder
P1
Completed28RCT, Double-blindLY2216684, Placebo, Lorazepam
NCT06370728
A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
Healthy
P1
Completed30Open-labelOrforglipron, Carbamazepine
NCT05994807
A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult Participants
Healthy Volunteers
P1
Completed33Open-labelDC-806, Itraconazole, Carbamazepine
NCT02497391
A Study of Different Particle Sizes of Evacetrapib in Healthy Participants
Healthy
P1
Completed95RCT, Open-labelEvacetrapib
NCT01836198
The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream
Healthy Volunteers
P1
Completed30RCT, Open-labelLY2409021, Gemfibrozil, Ketoconazole, Clarithromycin
NCT04451408
A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants
Alzheimer Disease, Healthy
P1
Completed139RCT, Double-blindLY3372993, Placebo
NCT03220126
A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy Participants
Healthy
P1
Completed72RCT, Open-labelLY3074828, LY900021
NCT06049108
A Study of Carbon-14-Labelled [14C] LY3871801 in Healthy Male Participants
Healthy
P1
Completed8Open-label[14C]-LY3871801
NCT04627064
ABEMA Alone or in COMBO With MK-6482
Clear Cell Renal Cell Carcinoma
P1
Completed11Open-labelAbemaciclib, MK-6482
NCT01825876
A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants
Healthy Volunteers
P1
Completed17Open-labelEvacetrapib, Warfarin
NCT04611789
A Study of LY3832479 (LY-CoV016) in Healthy Participants 1
Healthy
P1
Completed18RCT, Double-blindLY3832479, Placebo
NCT05999968
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Prostatic Neoplasms
P1
Terminated10Open-labelAbemaciclib, Darolutamide, LHRH agonist/antagonist
NCT01286818
A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
Colorectal Carcinoma
P1
Completed6Open-labelRamucirumab (IMC-1121B), Irinotecan, levofolinate, 5-Fluorouracil (5-FU)
NCT06180980
A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy Participants
Healthy
P1
Completed20RCT, Open-labelPirtobrutinib
NCT02745769
A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
Advanced Cancer, Colorectal Cancer
P1
Completed23Open-labelRamucirumab, Merestinib, Abemaciclib
NCT02604160
A Study of LY3113593 in Participants With Chronic Kidney Disease
Chronic Kidney Disease
P1
Completed7RCT, Single-blindLY3113593, Placebo
NCT03073213
A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris
Psoriasis
P1
Completed32RCT, Open-labelIxekizumab
NCT06169982
A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
P1
Completed56Open-labelLY3209590
NCT06627088
A Study of LY4100511 (DC-853) Mass Balance and Absolute Bioavailability of LY4100511 in Healthy Male Participants
Healthy
P1
Completed24Open-labelLY4100511 (DC-853), [14C]-LY4100511 (DC-853) Administered oral dose, LY4100511 (DC-853), [14C]-LY4100511 (DC-853)
NCT04085289
A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants
Healthy
P1
Completed30RCT, Double-blindGalcanezumab, Placebo
NCT01520220
Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms
Myeloproliferative Neoplasms of, Polycythemia Vera
P1
Completed100Open-labelLY2784544
NCT05974579
Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
P1
Completed8Open-label89Zr-DFO-AP-101
NCT02111083
A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants
Healthy Volunteers
P1
Completed38RCT, Double-blindInsulin Lispro
NCT02806960
A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
P1
Terminated12RCT, Single-blindNasal Glucagon
NCT02121834
A Study of LY3050258 in Healthy Participants
Healthy Volunteers
P1
Completed63RCT, Double-blindLY3050258, Placebo
NCT01919398
A Study of LY2940680 in Japanese Participants With Advanced Cancers
Neoplasm Metastasis
P1
Completed19Open-labelLY2940680
NCT06132126
A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
Healthy, Type 2 Diabetes Mellitus
P1
Completed66RCT, Double-blindLY3938577, Placebo, Insulin degludec
NCT05887999
A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus
Diabetes Mellitus, Type 1
P1
Completed30RCT, Double-blindLY3532226, Placebo
NCT07247357
A Study of LY4064809 in Healthy Adult Chinese Participants
Healthy
P1
Completed10Open-labelLY4064809
NCT03305822
A Study of LY900014 in Participants With Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
P1
Completed38RCT, Double-blindLY900014, Insulin Lispro
NCT01330953
A First Human Study of a Ferroportin Antibody
Healthy Volunteers
P1
Completed32RCT, Single-blindPlacebo, LY2928057
NCT06173895
A Relative Bioavailability Study of LY3454738 in Healthy Participants
Healthy
P1
Completed30RCT, Open-labelLY3454738
NCT01183650
A Study of Tadalafil in Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
P1
Completed24Open-labelTadalafil
NCT02906618
Study of LY3039478 in Healthy Participants
Healthy
P1
Completed12Open-labelLY3039478, 13C 15N 2H-LY3039478 IV
NCT01236118
A Study of LY2439821 in Rheumatoid Arthritis
Rheumatoid Arthritis
P1
Completed28Open-labelLY2439821
NCT02528396
To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
P1
Completed36RCT, Double-blindBioChaperone insulin lispro, Humalog®
NCT06045000
Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male Participants
Healthy Volunteers
P1
Completed8Open-labelDC-806, [14C]-DC-806
NCT02759107
A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
Healthy, Type 2 Diabetes Mellitus (T2DM)
P1
Completed142RCT, Double-blindTirzepatide, Placebo, Dulaglutide
NCT06945419
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
Healthy, Overweight
P1
Completed219RCT, Double-blindLY4086940, Placebo, LY4086940
NCT06345794
A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants
Healthy
P1
Completed50Open-labelLY4100511 (DC-853), Itraconazole, Fluconazole, Carbamazepine
NCT01725451
A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants
Healthy Participants
P1
Completed30RCT, Open-labelTestosterone
NCT01115751
A Study in Patients With Advanced or Metastatic Cancer
Metastases, Neoplasm
P1
Completed80Open-labelLY2780301
NCT03765502
A Study Comparing User Experience of Different Delivery Devices for Glucagon
Healthy
P1
Completed99RCT, Open-labelIM Glucagon
NCT04392271
A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants
Healthy
P1
Completed4Open-labelLY3372689
NCT02365571
A Study of LY3154207 in Healthy Participants
Healthy Participants
P1
Completed64RCT, Double-blindLY3154207, Placebo, Itraconazole
NCT06215521
A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy Participants
Healthy
P1
Completed31RCT, Double-blindPirtobrutinib, Placebo, Moxifloxacin
NCT02018887
A Study of LY2969822 in Healthy Participants
Healthy Volunteers
P1
Completed99RCT, Double-blindLY2969822, Placebo
NCT02672423
A Study of Abemaciclib in Healthy Participants
Healthy
P1
Completed127RCT, Open-labelAbemaciclib Capsules (Reference Formulation), Abemaciclib Tablet (Test Formulation)
NCT04914546
A Study of LY3819469 in Healthy Participants
Healthy
P1
Completed66RCT, Double-blindLY3819469, Placebo
NCT03222427
A Study of LY3314814 in Healthy Participants
Healthy
P1
Completed8Open-labelLY3314814, [13C415N3] LY3314814
NCT02123446
A Study of Cephalexin Capsules in Healthy Participants
Healthy Volunteers
P1
Completed28RCT, Open-labelCephalexin
NCT03748940
Study of LY3074828 in Healthy Participants
Healthy
P1
Completed60RCT, Double-blindLY3074828, Placebo, LY900021
NCT01771250
A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
P1
Completed15RCT, Open-labelInsulin Peglispro, Insulin Glargine
NCT04050670
A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes
Healthy
P1
Completed54RCT, Open-labelTirzepatide
NCT03148431
A Study of LY3002815 in Healthy Participants
Healthy
P1
Terminated45RCT, Double-blindLY3002815, Placebo
NCT01821703
A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants
Healthy Volunteers
P1
Completed24RCT, Double-blindLY3045697, Placebo, Spironolactone, Placebo
NCT03009162
Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function
Migraine
P1
Completed16Open-labelLasmiditan
NCT00576394
Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients
Glycemic Control
P1
Completed108RCT, Single-blindIV Insulin drip, Insulin
NCT01284335
A Safety Study in Participants With Advanced Solid Tumors
Advanced Solid Tumors
P1
Terminated234Open-labelGemcitabine, Docetaxel, Temozolomide, Cisplatin, Erlotinib, LY573636
NCT04515576
A Study of LY3493269 in Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
P1
Completed56RCT, Double-blindLY3493269, Dulaglutide, Placebo
NCT02046304
PP-Gemcitabine & External Beam Radiation-Sarcomas
Sarcoma
P1
Completed41Open-labelGemcitabine
NCT00277706
Impact of Parathyroid Hormone (PTH) on Osseous Cavity
Bone Loss, Periodontitis
P1
Completed40RCT, Double-blindFORTEO, Placebo
NCT01346358
A Study of IMC-CS4 in Subjects With Advanced Solid Tumors
Neoplasms
P1
Completed52Open-labelIMC-CS4
NCT01300260
Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
Diabetes Mellitus, Type 2
P1
Completed32RCT, Double-blindLY2189265, Placebo, Insulin, Glucose, Glucagon
NCT04682106
A Study of LY3493269 in Healthy Participants
Healthy
P1
Completed40RCT, Double-blindLY3493269, Placebo, Salcaprozate Sodium
NCT05630274
A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants
Healthy
P1
Completed32RCT, Double-blindSelpercatinib, Moxifloxacin, Placebo
NCT01995526
A Study of Insulin Peglispro in Healthy Male Japanese Participants
Healthy Volunteers
P1
Completed11Open-labelInsulin Peglispro
NCT01688635
A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy Participants
Healthy
P1
Completed91RCT, Double-blindLY2963016, US Approved Lantus
NCT03407118
A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus
Diabetes Mellitus, Type 1
P1
Completed31RCT, Double-blindLY900014, Insulin Lispro
NCT05042310
A Study of LY3541860 in Healthy Japanese and Non-Japanese Participants
Healthy
P1
Completed94RCT, Double-blindLY3541860, Placebo
NCT01870297
A Study of LY3025876 in Participants With Diabetes
Type 2 Diabetes Mellitus
P1
Completed72RCT, Double-blindLY3025876, Placebo, Liraglutide
NCT01925989
A Study of How Insulin Peglispro (LY2605541) and Insulin Glargine Affect the Breakdown of Fat and Sugar in Type 1 Diabetics
Type 1 Diabetes Mellitus
P1
Completed27RCT, Open-labelLY2605541, Insulin Glargine
NCT03019536
A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease
Alzheimer Disease
P1
Completed22RCT, Double-blindLY3303560 - IV, Placebo - IV, Florbetapir F 18, Flortaucipir F18
NCT05630287
A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of Carbon-14-Labelled [14C] Selpercatinib (LY3527723) in Healthy Male Participants
Healthy
P1
Completed12Open-label[14C]-Selpercatinib, Selpercatinib, [14C]-Selpercatinib
NCT01682135
A Study in Participants With Advanced Solid Tumors
Solid Tumor
P1
Completed28Open-labelRamucirumab
NCT07519525
A Study of [14C]-LY4064809 in Healthy Participants
Healthy
P1
Completed7Open-labelLY4064809, [14C]-LY4064809
NCT04881747
A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants
Healthy
P1
Completed47RCT, Open-labelLasmiditan
NCT02555449
A Study of [¹⁴C]-LY3202626 in Healthy Male Participants
Healthy
P1
Completed6Open-label[¹⁴C]-LY3202626
NCT01569126
A Study of LY110140 in Healthy Japanese Male Participants
Healthy Volunteer
P1
Completed56RCT, Double-blindLY110140, Placebo
NCT05841277
A Study of LY3819469 in Participants With Impaired and Normal Renal Function
Renal Insufficiency, Healthy
P1
Completed26Open-labelLY3819469
NCT02084082
Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects
Healthy
P1
Completed68RCT, Open-labelLinagliptin/Metformin ER FDC, Linagliptin, Metformin ER
NCT03367390
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
Type1 Diabetes Mellitus
P1
Completed30Open-labelInsulin Lispro
NCT00185575
Duloxetine for the Treatment of Dysthymia
Depressive Disorder
N/A
Completed24Open-labelduloxetine
NCT00136929
Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly
Myocardial Infarction
N/A
Unknown530RCT, Open-labelThrombolytic therapy
NCT05577169
Incorporating Mind-body Skills With Diabetes Education in Adolescents With Type 1 Diabetes
Type 1 Diabetes, Adolescent Behavior
N/A
Completed30RCT, Open-label—
NCT00953862
Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility
Attention Deficit Hyperactivity Disorder
N/A
Completed18Open-labelAtomoxetine
NCT03986502
Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
N/A
Completed30RCT, Open-label—
NCT01724580
Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE), Juvenile Dermatomyositis (JDM)
APPROVED_FOR_MARKETING——Baricitinib
NCT01117831
An Analysis of Diabetes Control in Puerto Rico
Diabetes Mellitus, Arterial Hypertension
Completed600——
NCT07675057
Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid Tumors
Urinary Bladder Neoplasms, Neoplasm Metastasis
AVAILABLE——Vepugratinib
NCT02890121
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:
Systemic Autoimmune Diseases
Completed2,006——
NCT01055808
Observational Study in Japanese Type 2 Diabetes Patients
Diabetes Mellitus, Type 2
Completed677—Insulins
NCT01080313
Head and Neck Cancer Registry (LORHAN)
Head and Neck Cancer
Completed26,000——
NCT00307268
Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD
Attention-Deficit/Hyperactivity Disorder (ADHD)
Completed195——
NCT07503613
Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
Vestibular Schwannoma
By Invite100——
NCT00211263
Bipolar Disorder Research Study for Ages 12 and Older
Bipolar Disorder
N/A
Completed750RCT, Open-labelmood stabilizer
NCT03338803
Real World Glycemic Effectiveness of Linagliptin
Diabetes Mellitus, Type 2
Completed11,001—Linagliptin
NCT01787903
The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA
Type 1 Diabetes Mellitus, Hypoglycemia Unawareness
N/A
Completed52RCT, Open-label—
NCT01067794
Chemotherapy in Treating Patients With Lung Cancer
Non Small Cell Lung Cancer
Completed1,610—Any platinum-based doublet chemotherapy
NCT03849612
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
N/A
Completed10Open-labelInsulin Lispro
NCT01109472
Improving Osteoporosis Care in a Home Health Setting
Osteoporosis
N/A
Completed1,009RCT, Single-blind—
NCT00712660
Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia
Schizophrenia
N/A
Completed146RCT, Double-blindantipsychotic dose increase
NCT00824603
Impact of Continuing Medical Education (CME) Insulin Program
Diabetes
Completed294——
NCT03559088
A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant Care
Migraine
N/A
Completed120Open-label—
NCT04681768
Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
Breast Cancer/ Metastatic Breast Cancer
Completed95—Abemaciclib
NCT00934908
Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine
Bipolar Disorder, Schizophrenia
N/A
Withdrawn—RCT, Double-blind—
NCT01056549
Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans
Hyperlipidemia
N/A
Completed15RCT, Single-blindexenatide
NCT01354015
Diabetes Remote Care Management System
Diabetes
N/A
Completed98RCT, Open-label—
NCT03830840
Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among US Latinos
Type2 Diabetes Mellitus, Cardiovascular Diseases
Completed405——
NCT01078805
Study of FORTEO Use in Subjects in the Community Setting
Osteoporosis
Completed4,167—FORTEO
NCT03652272
Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy
Medication Adherence
N/A
Completed301RCT, Open-label—
NCT02890134
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort
Systemic Autoimmune Diseases
Completed215——